gossypol has been researched along with baicalein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Giordano, MJ; Kim, HY; Moore, SA; Salem, N; Spector, AA | 1 |
2 other study(ies) available for gossypol and baicalein
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase derived.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Eicosapentaenoic Acid; Esculin; Flavanones; Flavonoids; Gossypol; Hydroxyeicosatetraenoic Acids; Isomerism; Lipoxygenase; Lipoxygenase Inhibitors; Masoprocol; Mice; Microcirculation; Oxygenases; Quercetin | 1991 |